明牌牛牛

| Join Desktop | Mobile
Free Post Information Website Trade Service Free Platform
You are here: Trade Valley » News » Industry News »Asia-Pacific Precision Medical Annual Ceremony & Boao Forum Opens

Asia-Pacific Precision Medical Annual Ceremony & Boao Forum Opens

Enlarge fontReduce font Release date: 2018-01-26 09:27 Views: 776
The 2017-2018 Asia-Pacific Precision Medical Annual Ceremony and Asia-Pacific Precision Medicine (2017-2018) is sponsored by the Hainan Provincial Health and Family Planning Commission as the guiding unit, hosted by the Asia-Pacific Precision Medical Industry Alliance, co-organized by Guangzhou Yijia and Jinye Culture, and co-organized by hundreds of authoritative organizations. (Boao) Forum kicked off at the Conrad Binya Hotel.
From the perspective of global precision medicine, this grand ceremony carried out top-level discussions on the ideas and characteristics of global precision medicine combined with the development of urban characteristics. It brings together leaders of healthy cities in the Asia-Pacific countries, authoritative academic experts from various countries, celebrities in government and enterprises, representatives of city health planning commissions, pioneers in precision medicine and business representatives, and world-renowned media to talk about the world's most cutting-edge technologies and take the pulse of the health industry. New directions for the future.

In October 2016, the State Council officially released the "Healthy China 2030" strategic plan, which for the first time raised the health of all people and people to the height of national strategy. Boao, Hainan has the only international medical tourism advanced zone approved by the state, and is responsible for exploring the country's medical and health industry. As the southernmost province of China, Hainan has incorporated the medical and health industry into the 12 leading industries in the province, taking advantage of the ecological environment and the advantages of international tourism island policies, focusing on diversified society for medical treatment and characteristic Chinese medicine, and actively exploring the medical industry and pensions. The deep integration of the tourism service industry has made the development of the medical and health industry the first breakthrough in the country. Statistics show that in recent years, the large health industry has accounted for more than 11% of Hainan's GDP, which is twice the national average.

The Asia-Pacific Precision Medicine Industry Alliance is a voluntary industry organization of the precision medicine industry in the Asia-Pacific region. It is a cross-regional and cross-border resource platform voluntarily formed by industry-university-research institutions engaged in precision medicine and social groups. It currently has nearly 3,000 global members and 300 global Think tank expert. As the organizer of the conference, the Asia-Pacific Precision Medical Industry Alliance set up this event site in Boao after extensive investigations, attracted worldwide attention and attention, received careful guidance from the Hainan Provincial Health and Family Planning Commission, and gained hundreds of Strong support from leading medical upstream and downstream enterprises.

At the opening ceremony of the first day and the Asia-Pacific Healthy Cities Exchange Summit, Wang Yunmin of the Hainan Provincial Health and Family Planning Commission released the development status of Hainan's medical and health industry to the world, which caused a strong response. Ms. Huang Dongmian, Secretary General of Hainan Medical Association, and Mr. Han Jiuhai, Chairman of Hainan Nongken Nanping Industrial Park Development Company attended the meeting.

China (Guangdong) Pilot Free Trade Zone Guangzhou Nansha New District Deputy Director Lin Liyin, Australian Consulate General Guangzhou Yinghua Lin Yinghua, UN Support Foundation Greater China Ms. Ren Yuting, President of the World Film Association Anthony, Korea Health Industry Promotion Institute China The president of the branch, Bai Chengzhang, and the British Consulate General in Guangzhou, Su Rui, respectively made a theme of medical health or investment environment introduction.
The event will last two days. On the afternoon of the first day, the 4th Asia-Pacific Precision Medicine Forum was also held. Associate Professor of Clinical Research at the University of Southern California, Dean Chen Changping, Dean of Kafford Medical Diagnostic Center, Director of Plastic Surgery, Asia University Medical College of Korea, and Chairman of Asia-Pacific Cartilage Repair Association Byung-Hyun Professor Min , Ms. Tia Walker, Vice Chairman of Global Strategy Department of Olympia, USA, Tia Walker, Professor of Shanghai Jiaotong University, Ph.D. Supervisor, and "Thousand Talents Plan" Specialist Professor Qi Nianmin, respectively, from the early diagnosis of automatic breast ultrasound for small breast cancer, cartilage repair, and healthy entertainment. New opportunities, stem cell preparation and other fields made wonderful academic sharing.
A group of high-quality precision medicine companies such as Cattibio, Qingdao Hankang, Beijing Xinke Yiren, Liveyon Regenerative Medicine Center of the United States, and representatives of Yuanyuan Gene, treat chronic diseases of children's dental pulp stem cells, early screening of cancer, and cardiovascular and cerebral vascular cholesterol Excellent projects were shared in the fields of therapy, high-end anti-aging and health management, and stem cell therapy.
At the AI Intelligent Medicine + Precision Medicine Forum on the 19th, Professor Hongxiang Hui, the director of Ruiyang Frontier Medical Center and a researcher at the University of California, Los Angeles Medical College (UCLA), published the opportunity and risk of artificial intelligence in medical and health care. Dr. Wang Tingchun, Chairman of Boji Pharmaceuticals, published "Drug R & D Strategies in the Context of Precision Medicine", Professor of Oncology, Hainan Medical College; Professor Bai Yujie, Director of the Silk Road (Ningxia) International Medical Laboratory New technology for liquid biopsy.
This conference attracted great attention from all countries in the world, and received the strong support of governments, consulates and international business friends. Representatives of consulates and business friends from various countries attending the event include:
Consulate General of the Republic of Korea in Guangzhou
Lee Hyun Ju Lee, Head of Overseas Business Department, Korea Health and Welfare Department
Choi Hyun Jae, Korea Health and Welfare Department
Korea Health Industry Promotion Institute Baek Seung-soo Baek, President of Seungsu China Branch
Representative of Korea Health Industry Promotion Institute
Representative of An, longchun, Korea Health Industry Promotion Institute
Korea Medical Holdings Andy Hong, General Manager
South Korea Medical Holdings Manager Tian Xiong Jeon, Woong
Kwon, Junhyun Senior Manager, Korea Medical Holdings
Li Guang, Managing Director of Korea Medical Holdings
Mr. Pei Baojun, President of PLUM GROUP and President of Global Cultural Industry Association
Ms. Tia Walker, Vice Chairman, Global Strategy, Olympia, USA
Ms. Ren Yuting, Chairman of the United Nations Support Foundation Greater China
Mr. Antonio Gellini (Anthony), President of the World Film Association
Commercial Office of the Australian Consulate General in Guangzhou / Business Consul of the Australian Trade and Investment Commission Anna Lin / Ms. Lin Yinghua
Ms. Feng Ling, Commercial Manager, Australian Consulate General in Guangzhou / Australian Trade and Investment Committee
Ms. Chen Zhihui from the Commercial Section of the Consulate General of Singapore in Guangzhou and the South China Office of Singapore International Enterprise Development Board
Mr. Su Rui, Medical Director, South China Medical Service, British Consulate General Guangzhou
The conference also welcomed think tank experts in the field of precision medicine in the alliance of South Korea, Britain, the United States and China. At the award ceremony on the evening of the 18th, the APMA Asia Pacific Precision Medicine Industry Alliance issued a letter of appointment to the newly joined think tank experts:
Professor Chen Changping, Associate Professor of Clinical Physics, University of Southern California
Professor Byoung-Hyun Min, Director of Plastic Surgery, Asia University Medical School, Korea
Dr. Wang Tingchun, Chairman of Boji Pharmaceuticals
Mr. Bai Yujie, Director and Professor of Silk Road (Ningxia) International Medical Laboratory, Institute of Oncology, Hainan Medical College
Professor Qi Nianmin, Professor, PhD Supervisor, and "Thousand Talents Plan" of Shanghai Jiaotong University
Dr. Cui Jihao, Director of Orthopedics, Panyu Branch, Guangzhou Second Affiliated Hospital
Professor Jin Gang, President of Cloud Health Gene Technology (Shanghai) Co., Ltd.
Mr. Zhang Jiangli, Co-founder and CEO of Shanghai Yuanyuan Biotechnology Co., Ltd., Bachelor of Biochemistry and MBA from Fudan University
Dr. Liu Chaoyu, CEO of Shenzhen Yinhe Biotechnology Co., Ltd.
Ms. Park Sula, Director and Professor, Renhe University, Korea
Professor Zhang Shengjun, MBA of Hopkins University, USA
Professor Hao Xinbao, Executive Deputy Dean of the First Affiliated Hospital of Hainan Medical College

The Asia-Pacific Precision Medical Alliance has more than 3,000 members worldwide. The Alliance think tank has attracted nearly 300 industry elites and experts from around the world to join. High-end platforms attract powerful partners. This conference has received the strong support of the following high-quality companies and member units in the industry:
Asian Stem Cells, Hainan Xinshengquan, Cattibio, Xinke Yiren, Kaiting International, Jing Yuechunhe, Future Bio, Boji Medicine, Dalian Jinma Group, Zhenzhili, Guangzhou Tianyi Cosmetics, Boao • Yinfeng Kangyang International Hospital, Yuanyuan Biological, Cloud Health, Zhongsheng Health, Huaxia Happiness Foundation, Ximeilai Health Management, Inho Bio, Family Portrait, Dongguan Anderson, Ningbo Good Voice, Hong Kong Puzi, Nuosai Gene, Changzhou Baiyi, Qingge, Quantum genes, human codon genes, top genes, iSike, Golden World Medicine, Hankang International, Mingjun Health, Pinggang Bio, Sunny stem cells, Intry, Agile, nuclear genes, stone medicine, Oriental Gene, Country Garden, Jingmeng, China Merchants Health, Corini, Zhenjiang Industrial Park, Zhonghe Health, Yike Canada, Benchmark Medical, Shang Jiayi, Watson Gene, Velk stem cells, Main Gene, Chongqing Donglunli Medical Research Hospital, Fuda Cancer Hospital, Arterial Network, Gene Valley and other nearly 500 enterprise leaders attended the meeting.

A number of high-quality companies have newly joined the Asia Pacific Precision Medical Industry Alliance family, namely:
Kaiting International joins the president unit of the Asia-Pacific Precision Medical Industry Alliance Medical Beauty Branch
Shenzhen Qingge Technology Co., Ltd. joined the executive vice president unit of Asia Pacific Precision Medical Industry Alliance "
Foshan Shunkangda Medical Technology Co., Ltd. joined the vice president unit of Asia Pacific Precision Medical Industry Alliance
Cathy (Shanghai) Biotechnology Co., Ltd. joins the governing unit of Asia Pacific Precision Medical Industry Alliance
  Asia Stem Cells joins Asia Pacific Precision Medical Industry Alliance
Shenzhen Human Code Gene Technology Co., Ltd. joins member unit of Asia Pacific Precision Medical Industry Alliance
Qingdao Hankang International Medical and Health Industry Co., Ltd. joined the member unit of Asia Pacific Precision Medical Industry Alliance
Beijing Xinke Yiren Technology Development Co., Ltd. joins members of Asia Pacific Precision Medical Industry Alliance
Guangzhou Hexie Medical Technology Co., Ltd. joins member unit of Asia Pacific Precision Medical Industry Alliance
Before the conference, "Top Ten Characters in the Asia-Pacific Genetic Testing Industry" and "Annual Recommended Companies in the Asia-Pacific Precision Medical Industry" set off an industry storm. In just ten days, it triggered millions of views and hundreds of thousands of votes. . Based on the background information of the participants, the expert review committee conducted professional review and offline voting. At the awards ceremony on the evening of the 18th, Chen Yong, deputy general manager of Watson Gene, King Kong, president of Cloud Health Gene, and Yu Xiao, chairman of Top Gene Bin, Liang Yaoming, Chairman of Jinyu Medical, Yang Xiao, CEO of Human Coding Gene, Gao Yuan, Co-founder and Chairman of Yuanyuan Gene, Fan Jianbing, Founder and CEO of Benchmark Healthcare, Zhang Hezi, Founder of Nuclear Gene, and Yu Rong, Founder of Main Gene Investment Han Yusheng, the founder and CEO of Burning Stone Medical, finally won the top ten figures of annual genetic testing.
Ms. Ding Xiaomei, Chairman of China Life Health Industry Group Co., Ltd., was awarded the Outstanding Person in the Precision Medicine Industry in Asia Pacific.
Cathy (Shanghai) Biotechnology Co., Ltd. won two awards: the most influential precision medical leader enterprise award and the most popular precision medical enterprise award.
Shenzhen Yinhe Biotechnology Co., Ltd. won the 2017 Most Valuable Investment Award in the genetic testing industry.
Henan Quanjiafu Health Technology Co., Ltd., Dongguan Anderson Metabolic Medicine R & D Co., Ltd. and Guangzhou E-shirt Biotechnology Co., Ltd. won the Asia Pacific Precision Medicine Most Innovative Enterprise Award.
Qianhai Intry Precision Medical (Shenzhen) Co., Ltd. won three awards: the Asia-Pacific Top Ten Precision Medical Brand Award, the most popular health management service agency award, and the sub-best innovative precision medical big data solution award.
Qingdao Hankang International Medical and Health Industry Co., Ltd. has won three awards: Top 10 Asia-Pacific Precision Medical Brand Award, Asia-Pacific Most Influential Precision Medical Consulting Agency Award, Asia-Pacific Most Popular Cross-Border Medical Tourism Service Award
Shenzhen Nuclear Gene Technology Co., Ltd. and Shanghai Oriental Gemma Gene Biotechnology Co., Ltd. won the Asia-Pacific Top Ten Gene Testing Brand Award.
Beijing Jingmeng Hi-Tech Stem Cell Technology Co., Ltd. Won: The Most Influential Precision Medical Leadership Enterprise Award.
Kaijie (Suzhou) Translational Medicine Research Co., Ltd. won the Leading Enterprise Award for the Most Innovative Precision Medical Overall Solution.
China Merchants Meilun Health Management Co., Ltd. won: Most Popular Health Management Service Agency Award
Zhongsheng Health Industry Group Co., Ltd. won: Most Influential Precision Medical Leadership Award, Asia-Pacific Top Ten Precision Medical Brand Award
Hainan Xinshengquan International Cell Therapy Hospital won: Most Influential Stem Cell Medical Leadership Enterprise Award
Beijing Xinke Yiren Technology Development Co., Ltd. won the Most Influential Precision Medical Leadership Award

On the afternoon of the 19th, hundreds of entrepreneurs and experts led by the Asia-Pacific Precision Medical Industry Alliance, the organizer of the conference, visited the Boao Lecheng International Medical Advanced Zone and related enterprises.
The organizer stated that in 2018, the 100 cities tour exhibition and high-end resources matchmaking will continue in Guangzhou, Shenzhen, Changsha, Wuhan, Xiamen and other places. The 5th Asia-Pacific Precision Medical Forum will also be grandly opened in Pazhou, Guangzhou on June 29; Alliance The business school will start its trip to Korea in May, and the precision medical medical transformation base will also be launched within the year.

Reports from mainstream media such as CCTV, China News Service, Guangdong Radio and Television, Southern Television, Phoenix Satellite TV, Sina.com, Youku.com, Today's Headline, MICE and other professional media, as well as professional media in the medical and health fields.

Share and favorite: 本文关键字: News search Tell friends to close the window to print this article Keywords:
Recommended Photo
sponsor link
Recommended information
sponsor link